awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40539487-49EB2612-02EB-4F37-9658-6702E3D87276
Q40539487-49EB2612-02EB-4F37-9658-6702E3D87276
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40539487-49EB2612-02EB-4F37-9658-6702E3D87276
Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia.
P2860
Q40539487-49EB2612-02EB-4F37-9658-6702E3D87276
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40539487-49EB2612-02EB-4F37-9658-6702E3D87276
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
123c4f6dfd39d674b942b9196b85d999548ee965
P2860
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.